Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,273,086
-$9,038,157 QoQ
Shares Held
63,700
-65.8% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 305 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. ANIP ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in ANIP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,273,086 | 63,700 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,311,243 | 186,102 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $24,818,893 | 314,402 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,997,823 | 272,902 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,377,251 | 128,387 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,695,658 | 219,502 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,718,224 | 175,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,622,785 | 245,102 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,985,151 | 156,802 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,394,905 | 135,902 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,271,328 | 95,599 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,299,292 | 39,602 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,299,886 | 61,302 | Shares | Sole | 2023-08-11 | |
| 2022-03-31 | $2,490,602 | 88,602 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,538,972 | 98,502 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,913,406 | 58,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,361,633 | 67,379 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,163,400 | 115,202 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,550,684 | 156,704 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,034,086 | 143,002 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,607,756 | 173,400 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,686,102 | 262,300 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||